阿斯彭：藥物替西帕肽在南非獲批，用於慢性體重管理

Zhitong
2025.10.13 08:51

On October 13th, it was reported that Aspen Pharmacare announced that the South African Health Products Regulatory Authority has approved its once-weekly prescription treatment drug Mounjaro for an additional indication, to be used as an adjunct to diet and exercise for chronic weight management, effective from October

來源：Zhitong 本文版權歸屬原作者/機構所有。
當前內容僅代表作者觀點，與本平台立場無關。內容僅供投資者參考，亦不構成任何投資建議。如對本平台提供的內容服務有任何疑問或建議，請聯絡我們。